These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9467486)
1. Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study. Oxley JD; Abbott CD; Gillatt DA; MacIver AG Br J Urol; 1998 Jan; 81(1):109-15. PubMed ID: 9467486 [TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Epstein JI; Woodruff JM Cancer; 1986 Jan; 57(1):111-9. PubMed ID: 2416422 [TBL] [Abstract][Full Text] [Related]
3. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study. Sasor A; Wagrowska-Danilewicz M; Danilewicz M Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901 [TBL] [Abstract][Full Text] [Related]
4. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin? Prendeville S; Al-Bozom I; Compérat E; Sweet J; Evans AJ; Ben-Gashir M; Mete O; van der Kwast TH; Downes MR Histopathology; 2017 Dec; 71(6):926-933. PubMed ID: 28756619 [TBL] [Abstract][Full Text] [Related]
5. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Tavora F; Epstein JI Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142 [TBL] [Abstract][Full Text] [Related]
6. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Soini Y; Pääkkö P; Nuorva K; Kamel D; Lane DP; Vähäkangas K Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):223-8. PubMed ID: 1413488 [TBL] [Abstract][Full Text] [Related]
8. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity. Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288 [TBL] [Abstract][Full Text] [Related]
9. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Herawi M; Epstein JI Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076 [TBL] [Abstract][Full Text] [Related]
11. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060 [TBL] [Abstract][Full Text] [Related]
12. Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia. Humphrey PA; Swanson PE Pathol Res Pract; 1995 Sep; 191(9):881-7. PubMed ID: 8606869 [TBL] [Abstract][Full Text] [Related]
13. Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors. Hernes EH; Linja M; Fosså SD; Visakorpi T; Berner A; Winderen M; Koivisto PA BJU Int; 2000 Aug; 86(3):240-7. PubMed ID: 10930923 [TBL] [Abstract][Full Text] [Related]
14. Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma. Szende B; Romics I; Minik K; Szabó J; Torda I; Lovász S; Szomor L; Tóth L; Bély M; Kerényi T; Bartók K; Végh A Prostate; 2001 Oct; 49(2):93-100. PubMed ID: 11582587 [TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in prostate cancers of different histologic types. Losi L; Di Gregorio C; Brausi M; Fante R; Hurlimann J Pathol Res Pract; 1994 Apr; 190(4):384-8. PubMed ID: 8078807 [TBL] [Abstract][Full Text] [Related]